Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
32.95
-1.74 (-5.02%)
Nov 20, 2026, 3:04 PM CST
SHE:300573 Market Cap
SHE:300573 has a market cap or net worth of 11.69 billion as of November 20, 2026. It is the 6,758th most valuable company in the world and the 1,187th biggest in China. Its market cap has decreased by 34.10% in one year.
Market Cap
11.69B
Enterprise Value
11.26B
Revenue
2.81B
Global Rank
Country Rank
#1,187 China
PE Ratio
14.69
ChartMarket Cap Chart
Since December 8, 2016, SHE:300573's market cap has increased from 594.40M to 11.69B, an increase of 1,867.46%. That is a compound annual growth rate of 34.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 11.69B | -32.49% |
| Dec 31, 2025 | 17.32B | 41.64% |
| Dec 31, 2024 | 12.23B | -46.16% |
| Dec 29, 2023 | 22.72B | 105.08% |
| Dec 30, 2022 | 11.08B | -1.66% |
| Dec 31, 2021 | 11.26B | 47.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Kangtai Biological Products | 12.95B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 12.92B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.64B |
| Guobang Pharma | 12.37B |
| Harbin Pharmaceutical Group | 12.37B |
| Shenzhen Hepalink Pharmaceutical Group | 12.18B |
| ApicHope Pharmaceutical Group | 11.85B |
| Porton Pharma Solutions | 11.62B |